Contact
Please use this form to send email to PR contact of this press release:
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
TO:
Please use this form to send email to PR contact of this press release:
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
TO: